Depression News

Alto Neuroscience Inc. announced that Alpha Wave Ventures has made a $25 million equity investment to its Series B funding, bringing the total to roughly $60 million as Alto seeks to expand its roster of mental-health related therapeutics.

A California-based digital mental health provider announced the expansion of its comprehensive care services for organizations beyond the United States, beginning with the United Kingdom.

Cognitive behavioral therapy reduced depression and anxiety and improved heart-related quality of life and adherence among younger patients receiving cardiac rehabilitation, researchers reported.

According to a recently released poll, mental health among U.S. workers has improved minimally from the depth of the COVID-19 pandemic, with about half of respondents stating they would like online assessments of their mental well-being.

A biopharmaceutical company announced the first participants have been dosed in its phase 1 clinical trial of PH10, an investigational pherine nasal spray to treat major depressive disorder.

The needs of families are largely unmet when a parent is hospitalized for a mental illness, with the need for a broad range of care models required to address these gaps, according to a study published in BMC Psychiatry.

A physician-owned acute care practice and a virtual psychiatry and therapy practice have announced a partnership that aims to provide comprehensive acute medical and psychiatric care services to EDs across the country.

Adverse childhood experiences, such as having a depressive episode or suffering physical abuse, were likely to contribute to risky drinking among children of alcoholics, researchers wrote in BMC Psychiatry.

In an update to its guidance on depression, ACP now recommends cognitive behavioral therapy or second-generation antidepressants as an initial treatment for patients in the acute phase of moderate to severe major depressive disorder.

Sleep quality in patients with type 1 diabetes may be improved with disease management as well as interventions supporting resilience and reducing negative emotions, researchers reported in BMC Psychiatry.